Neuroprotective, antimicrobial, antioxidant, chemotherapeutic, and antidiabetic properties of Salvia Reuterana: A mini review by Jafari, Elham. et al.




Neuroprotective, antimicrobial, antioxidant, chemotherapeutic, and 















Isfahann Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Science, Isfahan 
University of Medical Sciences, Isfahan, I. R. Iran 
2
 Neurosciences Research Center, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, I. R. Iran  
3
 Medicinal Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, I. R. Iran 
4
Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, I. R. Iran 
 
Article history: 
Received: Apr 30, 2014 
Received in revised form:  
Jun 21, 2014 
Accepted: Jul 8, 2014 
Vol. 5, No. 1, Jan-Feb 2015, 
10-16. 
 










Salvia Reuterana  
Abstract 
Objectives: Herbal medicine is known as a valid alternative 
treatment. Salvia Reuterana, which has been used in the Iranian 
traditional medicine, is mostly distributed in the central highlands 
of Iran. Salvia Reuterana is a medicinal herb with various 
therapeutic usages. The aim of the present review is to take 
account of pharmacological properties of Salvia Reuterana.  
Materials and Methods: The present review summarizes the 
literature with respect to various pharmacological properties of 
Salvia Reuterana.  
Results: Salvia Reuterana possesses neurological, antimicrobial, 
antioxidant, chemotherapeutic, and antidiabetic properties.  
Conclusions: Salvia Reuterana can be used as an alternative for 
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Introduction  
In the recent years we have witnessed 
rapidly increasing advances in the field of 
herbal medicine. World health 
organization (WHO) has reported that 
more than 80% of the world's population 
takes advantages of traditional medicine as 
their primary therapeutic needs on the 
grounds of their natural origin and low 
side effects. In the long history of the use 
of herbal medicines, human interactions 
with the environment have been thought to 
be a key element and it appears that 
systematic screening of medicinal herbs 
may discover novel effective compounds 
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(Javidnia et al., 2009; Kamal & Jawaid, 
2011). 
Salvia is one of the largest genus of the 
Lamiaceae with over 900 species 
distributed throughout the world, 
especially in tropical and temperate areas 
(Masoud et al., 2011; Salimpour et al., 
2011).  
In Iran, the genus Salvia (Sage) includes 
58 species, of which 17 are known to be 
endemic. The name Salvia also refers to 
the Latin word Salvare, which means 
healer. Species of Salvia have traditionally 
been utilized in folk medicine to preclude 
stomach ailments and the common cold 
(Amiri, 2007; Naser Moadeli et al., 2013). 
Iranian traditional medicine have derived 
benefits of infusion and decoction of aerial 
parts of such genus as tonic, carminative, 
digestive, antispasmodic, and anti-
inflammatory agents for treatment of 
diseases stemming from reactive oxygen 
species (ROS) (Karamian et al., 2013). 
In addition to using Salvia species in 
cosmetics, perfumery, and the 
pharmaceutical industry, they have widely 
been utilized as herbal tea and food plant 
material flavoring (Nadaf et al., 2012). 
Such species contain monoterpene with 
antiseptic characteristics; even so, the 
compounds obtained from these species 
generate cellular DNA synthesis decline, a 
key factor in diagnosis and treatment of 
cancer (Masoud et al., 2011). The 
consequent metabolites, namely essential 
oils and plant extract of some Salvia 
species, are believed to exert antioxidant, 
antimicrobial, antifungal, anti-
inflammatory, carminative, diuretic, 
hemostatic, spasmolytic, and aromatic 
effects (Sajjadi & Shahpiri, 2004). For 
example, aerial parts of Salvia officinalis, 
Salvia sclare, Salvia macrosiphon, Salvia 
aegyptica, and Salvia Reuterana (S. 
Reuterana) have been used as 
hypoglycemic, tonic, antimicrobial, anti-
inflammatory, and anti-anxiety herbal 
drugs, respectively (Rabbani et al., 2005). 
Phytochemical assessments have revealed 
that some species of Salvia contain 
phenolic acids, phenolic glycosids, 
flavonoids, anthocyanins, coumarins, 
polysaccharides, strols, terpenoid, and 
essential oils (Amiri, 2007; Salimpour et 
al., 2011). It has been demonstrated that 
morphological characters of six Salvia 
species, that is, Salvia atropatana, Salvia 
oligophylla, Salvia aethiopis, Salvia 
sclraea, S. Reuterana, and Salvia 
macrosiphon are similar particularly in 
their leaves, trichomes, and flowers 
(Salimpour et al., 2011). 
S. Reuterana Boiss refers to a perennial 
herb growing in the central highlands of 
Iran. The plant is known as Mariam Goli 
Esfahani in Persian. Evidence form a study 
on volatile constituents of S. Reuterana 
suggested that 21 components existed in 
the oil of the plant. It was shown that (E)-
beta-ocimene (32.3%), alpha-gurjunene 
(14.1%), germacrened-D (11.2%), and 
hexyl acetate (7.6%) were the major 
constituents (Mirza & Sefidkon, 1999). 
Morphological and phytochemical 
diversity of intra- and inter- population of 
the plant have been assessed in some areas 
of Iran to domesticate this valuable plant 
(Masoud et al., 2011). Furthermore, 
pharmacological studies have recently 
attempted to evaluate anti-anxiety 
(Andalib et al., 2011; Gilhotra & Dhingra, 
2008; Kalia et al., 2012; Rabbani et al., 
2005; Rabbani et al., 2011; Verma et al., 
2010), hypnotic (Andalib et al., 2011), and 
antibacterial (Javidnia et al., 2009) 
properties of the plant. The present review 
summarizes the literature reported by far 
regarding the neurological, antimicrobial, 
antioxidant, chemotherapeutic, and 
antidiabetic properties of S. Reuterana. 
 
Pharmacological properties of S. 
Reuterana 
Use of S. Reuterana extract in treatment of 
anxiety 
Anxiety, which is a generalized mood 
condition without an identifiable triggering 
stimulus, is known as a common disorder 
in todays' communities. It was shown that 
this disorder may last many years, and 
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corresponds to significant personal 
distress, decreased quality of life, and 
increased morbidity and mortality (ref). 
Main drawbacks of anxiety drug therapy 
include co-morbid psychiatric disorders 
and increase in the medication dose, giving 
rise to deleterious side effects. Recently, 
there has been an increasing interest in 
assessing plants employed for treatment of 
sleep disorders and related diseases in 
traditional and alternative systems of 
medicine (Gilhotra & Dhingra, 2008; Kalia 
et al., 2012; Verma et al., 2010). 
Anxiolytic effect of S. Reuterana was 
shown by Rabbani et al. (Rabbani et al., 
2005). The authors demonstrated that 
hydroalcoholic extract (100 mg/kg, po) 
exerted anxiolytic-like effect in the 
elevated plus maze, and anxiety level 
declined in EPM model test in mice. The 
extracts showed sedative impact that was 
much lower than diazepam in the 
locomotor activity test (Rabbani et al., 
2005). The sedative property was further 
supported by its effects upon locomotor 
activity bringing about sedation at a dose 
of 100 mg/kg (Rabbani et al., 2005). It was 
also shown that doses lower than 100 
mg/kg did neither alter the locomotor 
activity nor exerted a remarkable 
anxiolytic impact (Rabbani et al., 2005). 
Moreover, Vaseghi et al., reported that the 
sedative effect of S. Reuterana extract 
(100 mg/kg) was much lower than those 
exerted by diazepam, elsewhere (Vaseghi 
et al., 2013). This showed a better profile 
as an anxiolytic medicine. The authors also 
argued that increase in dose of the extract 
may increase sedative properties but not 
anxiolytic effects (Vaseghi et al., 2013). 
The anxiolytic mechanism was postulated 
to affect GABA receptors (Kamal & 
Jawaid, 2011; Rabbani et al., 2005; 
Rabbani et al., 2011). 
 
Hypnotic effect of S. Reuterana for 
treatment of insomnia 
Insomnia is a common disorder 
characterized by difficulty falling asleep 
giving rise to multiple nervous problems. 
It has been reported that 10 to 20 percent 
of adults suffer from chronic insomnia. 
Interest has recently been focused on 
utilizing medicinal herbs to abate insomnia 
owing to deleterious side effects of 
synthetic sleep medicines. In Iranian folk 
medicine, Coriandrum sativum, Salvia 
leriifolia, S. Reuterana, and Stachys 
lavanduli folia have been utilized against 
insomnia. The aerial parts of S. Reuterana 
have traditionally been used on the 
grounds of its sedative and anxiolytic 
properties. The mechanism of inhibition of 
acetylcholinesterase by constituents of S. 
Reuterana, which is responsible for its 
sedative effects, was supported by Perry et 
al. (Perry et al., 2003). It was also reported 
that Miltirone inhibits the binding of [3H] 
flunitrazepam to central benzodiazepine 
receptor. 
 
Use of S. Reuterana extract as 
antimicrobial agents 
Given the fact that bacterial infections 
are serious health problems, a considerable 
amount of literature has been published 
with regard to new antimicrobial drugs 
from various sources (e.g., 
microorganisms, animals, and plants). 
Broadly speaking, it is difficult to ignore 
plant extracts and essential oils as 
potentially useful sources of antimicrobial 
compounds. The crude herbal extracts of 
aromatic plants have traditionally been 
used for food preservation and also as 
antimicrobials (Batooli et al., 2013; 
Javidnia et al., 2009; Sonboli et al., 2006). 
Compared to current antimicrobials, herbal 
antimicrobial compounds inhibit bacterial 
growth through different mechanisms. 
Such property may be  clinically valuable 
against resistant microbial strains (Javidnia 
et al., 2009). 
Javidnia et al. assessed antimicrobial effect 
of methanolic extracts of various parts of 
eleven indigenous wild plant species used 
in  Iranian folk medicines for treatment of 
infection of nine species of 
microorganisms, namely Escherichia coli, 
Staphylococcus aureus, Staphylococcus 
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epidermis, Pseudomonas aeruginosa, 
Klebsiella pneumoniae, Salmonella typhi, 
Bacillus subtilis, Aspergillus niger, and 
Candida albicans (Javidnia et al., 2009). 
By means of disk diffusion (0.5, 1, 2, and 
4 mg/disk) and minimal inhibition 
concentration (MIC), the antimicrobial 
efficacy was assessed and Salvia species 
showed the most active antimicrobial 
property (Javidnia et al., 2009). 
 
Use of S. Reuterana extract as a 
chemotherapeutic agent 
Medicinal herbs are important sources 
of potential chemotherapeutic agents used 
to treat cancers. Over 400 compounds have 
been obtained from plants using 
cytotoxicity bioassay. For instance, 
vinblastin, vincristine, etoposide, and taxol 
are plant-derived compounds that are 
accredited as anti-cancer drugs. A majority 
of these chemotherapeutic drugs exert anti-
cancer impact through arresting cells at 
different stages of the cell cycle and 
subsequently causing apoptotic cell death. 
Interestingly, most of these agents possess 
exclusively a limited anti-solid tumor 
activity and exert a host of side effects. 
Investigations on new anti-cancer drugs 
with a higher potency and specificity 
against cancer cells have great values in 
medicine (Amirghofran et al., 2010; Amiri, 
2007; Javidnia et al., 2009). Antitumor 
activity of several plants embodying Salvia 
species against different cell lines namely, 
Hela (Cervix epitheloid carcinoma), Raji 
(Burkitt's lymphoma), Fen (bladder 
carcinoma), K562 (myelogenous 
leukemia), and Jurkat (T cell leukemia), 
which were obtained from Iranian cell 
bank, was investigated by Amirghofran et 
al. (Amirghofran et al., 2010). The authors 
argued that, compared to other herbs, 
Salvia possesses more cytotoxic activity 
against tumor cells, which is due to the 
presence of various cytotoxic compounds 
in different Salvia species. Salvicine, 
salvinal, and tanshinone are cases in point. 
This compound has been utilized for 
treatment of breast cancer. The highest 
inhibitory effect of Salvia species was 
observed in S. Reuterana extract. In spite 
of the fact that the inhibitory effect of the 
extract on Jurkat, K562, Fen, and Hela 
cells failed to reach 50%, a strong 
inhibitory effect was seen on the Raji cell 
line as 50% of Raji cells growth was 
inhibited by the extract (21±0.8 μg/ml) 
(Amirghofran et al., 2010). The authors 
also suggested S. Reuterana for further 
investigations to discover the effective 
anti-cancer component (Amirghofran et 
al., 2010). 
 
Use of S. Reuterana extract as an 
antioxidant agent 
Oxidative stress includes a situation 
wherein a serious imbalance exists 
between the generations of reactive 
oxygen species (ROS) and antioxidant 
defense mechanisms, and gives rise to 
potential tissue dysfunction and damage. 
ROS are produced in the early and 
advanced stages of glycation. The 
glycation phenomenon is attributed to the 
nonenzymatic and non-oxidative covalent 
linkage of glucose molecule to protein. It 
was demonstrated that non-enzymatic 
protein glycation initially occurs by the 
creation of a Schiff base between amino 
groups of the protein chain and the 
aldehyde (or keto) groups of the sugars. 
Afterwards, the Schiff base enters a 
number of reactions to produce fluorescent 
brown pigments that is called advanced 
glycation products (Esmaeili et al., 2010; 
B Nickavar, 2012; Bahman Nickavar et al., 
2007). The antioxidant property of 
methanolic extract of S. Reuterana was 
assessed by Esmaeili et al. using various 
established in vitro systems involving 
ferric reducing antioxidant power 
(Esmaeili et al., 2010), Trolox equivalent 
antioxidant capacity assay, and scavenging 
of 1,1-diphenyl-2-picrylhydrazyl radical 
(Esmaeili et al., 2010; Ghomi et al., 2012; 
Bahman Nickavar et al., 2007). The 
authors confirmed the highest scavenging 
activity in methanolic extract of S. 
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AJP, Vol. 5, No. 1, Jan-Feb 2015                                                    14 
Reuterana (15.01±1.00 µg/ml) (Esmaeili 
et al., 2010).  
Moreover, inhibitory effect of the plant 
on glycation- and oxidation-dependent 
damages to albumin induced by fructose 
was studied (Esmaeili et al., 2010). The 
methanolic extract derived from the aerial 
parts of S. Reuterana, as a 
polyphenolicrich extract, exerted a high 
inhibitory effect upon formation of AGEs 
(advanced glycation end products) up to 
53.3% with a concentration of 50 µg/ml as 
the same concentration of aminoguanidine 
(AG) that leaded to 60.4% inhibition, 
using different in vitro glycation models 
(Esmaeili et al., 2010). Methanolic extract 
of the plant also showed a significant 
decline in protein carbonyl formation and 
increase in protein thiol levels and 
protected structural changes of BSA 
(bovine serum albumin) from glycation 
processes, which may pertain to its 
antioxidative activity (Esmaeili et al., 
2010). 
 
α-Amylase inhibitory activities of S. 
Reuterana 
α-Amylase refers to one of the enzymes 
contributing to catalyzing the breakdown 
of starch to maltose and subsequently to 
glucose, the only sugar able to be 
consumed by the body. The inhibition of 
such enzymes diminishes blood glucose 
level. Herbs and their constitutions have 
recently attracted much attention because 
they can abate diabetes, and a host of 
researchers has worked on hypoglycemic 
agents from medicinal plants. The 
evidence from the published literature 
suggests that polyphenols and flavonoids 
are among natural active antidiabetic 
compounds. It has been demonstrated that 
such compounds possess various 
biological properties, involving 
carbohydrate hydrolyzing enzyme 
inhibition and antioxidant activity. 
Nickavar et al. studied α-Amylase 
inhibitory activities of ethanol extracts 
derived from six Iranian Salvia species by 
means of in vitro model (Bahman 
Nickavar et al., 2010). It was shown that 
an increase in graded concentrations of the 
S. Reuterana extract diminished α-amylase 
activity from 1.19±0.45 to 25.01±1.68%. 
Nevertheless, the inhibitory activity of S. 
Reuterana on α-amylase was weak and 
failed to reach the 50% inhibition level of 
enzyme activity (Bahman Nickavar et al., 
2010). 
 
Effect of S. Reuterana aerial parts on 
serum parameters in normal and 
streptozotocin-induced diabetic rats 
Eidi et al. assessed the effect of aerial 
parts of Salvia Reuterana upon serum 
parameters (i.e., glucose, triglycerides, 
total cholesterol, urea, uric acid, creatinine, 
aspartate aminotransferase (AST), and 
alanine aminotransferase (ALT)) in normal 
and diabetic rats (Eidi et al., 2012). 
Following oral treatment with S. Reuterana 
extract (0.25 and 0.5 g/kg body weight) 
and glibenclamide (standard antidiabetic 
drug) for a period of 14 days, a significant 
decline in serum glucose, triglycerides, 
total cholesterol, urea, uric acid, creatinine, 
AST, ALT, and increased plasma insulin 
in streptozotocin-induced diabetic rats 
were reported compared to normal rats. 
The authors concluded that extracts from 
this plant illustrate a dose-dependent 
activity that is comparable to the standard 
antidiabetic drug, glibenclamide (Eidi et 
al., 2012). 
 
Medicinal plants are utilized by 
approximately 80% of the population of 
the world (ref). In spite of successes of 
synthetic drugs, they have a number of 
adverse effects. Natural remedies are 
becoming popular alternatives owing to 
fewer side effects (ref). Salvia is one of the 
largest genuses of the Lamiaceae including 
roughly 900 species throughout the world. 
S. Reuterana Boiss, which is known as 
Mariam Goli Esfahani in Persian, is a 
perennial herb growing in the central 
highlands of Iran (ref). Pharmacological 
studies have thus far confirmed its 
antibacterial, antifungal, carminative, 
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antianxiety, and antioxidant properties. 
Neurological, antimicrobial, 
chemotherapeutic, antioxidant, α-amylase 
inhibitory, and antidiabetic properties of S. 
Reuterana extract have been demonstrated 
by recent studies (ref). The anxiolytic 
mechanism affects GABA receptors, while 
the mechanism of inhibition of 
acetylcholinesterase contributes to its 
sedative effects (ref). Methanolic extract of 
S. Reuterana also causes a significant 
decline in protein carbonyl formation and 
increase in protein thiol levels and 
protected structural changes of BSA 
(bovine serum albumin) from glycation 
processes and this may be involved in such 
antioxidative activity (ref). Little, 
however, is known about the active 
component and mechanism of the 
antimicrobial, chemotherapic, α-amylase 
inhibitory, and serum parameters’ 
lowering properties of S. Reuterana. Thus, 
further research regarding S. Reuterana 
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